Cadila Healthcare gets approval for Rs 5000 crore of FDI proposal
Based on the recommendations of Foreign Investment Promotion Board (FIPB) in its 229th meeting held on 21 December 2015, the Government has approved five (05) proposals of Foreign Direct Investment (FDI) amounting to Rs 6050.10 crore.Among the major proposals cleared, government has approved the FDI proposal of Cadila Healthcare amount to Rs 5000 crore. The approval has been granted for fresh equity infusion of up to Rs 5000 crore under FDI Route by QIBs through Qualified Institutional Placement under Chapter VIII (QIP) of SEBI ICDR Regulations on a Private Placement basis for the expansion of the business.
The government has also approved the FDI proposal of Recipharm Participation B.V allowing to incorporate a WoS in India, which will be engaged in the business of investing in other companies.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
